Report Detail
Global (United States, European Union and China) Drug-Eluting Stents Market Research Report 2019-2025
- RnM3691636 |
- 23 August, 2019 |
- Global |
- 121 Pages |
- QYResearch |
- Other
A drug eluting stent (DES), also known as a drug-eluting stent, carries a drug through a polymer coated on the surface of a metal stent. When the stent is placed in an intravascular lesion, the drug is coated in the polymer coating. The biological effect is exerted by controlled release to the cardiovascular wall tissue by means of elution. The currently marketed drug-eluting stents include a rapamycin-eluting stent and a paclitaxel-eluting stent, both of which prevent in-stent restenosis by inhibiting smooth proliferation of smooth muscle cells.
North America dominated the global Drug Eluting Stent Market with a revenue share of 37% in 2017. The dominance of the region was majorly attributed to stringent regulatory guidelines for medical device manufacturing and approval. In addition, the reimbursement coverage coupled with a high incidence rate of artery diseases is anticipated to augment the market growth in North America.
In 2019, the market size of Drug-Eluting Stents is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drug-Eluting Stents.
This report studies the global market size of Drug-Eluting Stents, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Drug-Eluting Stents production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Boston Scientific
Medtronic, Inc.
Abbott
Lepu Medical
MicroPort Scientific Corporation
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)
Market Segment by Product Type
Rapamycin
Paclitaxel
Everolimus
Others
Market Segment by Application
Angina Pectoris
Myocardial Infarction
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Drug-Eluting Stents status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Drug-Eluting Stents manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Drug-Eluting Stents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Drug-Eluting Stents Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Rapamycin
- 1.3.3 Paclitaxel
- 1.3.4 Everolimus
- 1.3.5 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Drug-Eluting Stents Market Share by Application (2019-2025)
- 1.4.2 Angina Pectoris
- 1.4.3 Myocardial Infarction
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Drug-Eluting Stents Production Value 2014-2025
- 2.1.2 Global Drug-Eluting Stents Production 2014-2025
- 2.1.3 Global Drug-Eluting Stents Capacity 2014-2025
- 2.1.4 Global Drug-Eluting Stents Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Drug-Eluting Stents Market Size CAGR of Key Regions
- 2.2.2 Global Drug-Eluting Stents Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Drug-Eluting Stents Capacity by Manufacturers
- 3.1.2 Global Drug-Eluting Stents Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Drug-Eluting Stents Revenue by Manufacturers (2014-2019)
- 3.2.2 Drug-Eluting Stents Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Drug-Eluting Stents Market Concentration Ratio (CR5 and HHI)
- 3.3 Drug-Eluting Stents Price by Manufacturers
- 3.4 Key Manufacturers Drug-Eluting Stents Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Drug-Eluting Stents Market
- 3.6 Key Manufacturers Drug-Eluting Stents Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Rapamycin Production and Production Value (2014-2019)
- 4.1.2 Paclitaxel Production and Production Value (2014-2019)
- 4.1.3 Everolimus Production and Production Value (2014-2019)
- 4.1.4 Others Production and Production Value (2014-2019)
- 4.2 Global Drug-Eluting Stents Production Market Share by Type
- 4.3 Global Drug-Eluting Stents Production Value Market Share by Type
- 4.4 Drug-Eluting Stents Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Drug-Eluting Stents Consumption by Application
6 Production by Regions
- 6.1 Global Drug-Eluting Stents Production (History Data) by Regions 2014-2019
- 6.2 Global Drug-Eluting Stents Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Drug-Eluting Stents Production Growth Rate 2014-2019
- 6.3.2 United States Drug-Eluting Stents Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Drug-Eluting Stents Import & Export
- 6.4 European Union
- 6.4.1 European Union Drug-Eluting Stents Production Growth Rate 2014-2019
- 6.4.2 European Union Drug-Eluting Stents Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Drug-Eluting Stents Import & Export
- 6.5 China
- 6.5.1 China Drug-Eluting Stents Production Growth Rate 2014-2019
- 6.5.2 China Drug-Eluting Stents Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Drug-Eluting Stents Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Drug-Eluting Stents Consumption by Regions
- 7.1 Global Drug-Eluting Stents Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Drug-Eluting Stents Consumption by Type
- 7.2.2 United States Drug-Eluting Stents Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Drug-Eluting Stents Consumption by Type
- 7.3.2 European Union Drug-Eluting Stents Consumption by Application
- 7.4 China
- 7.4.1 China Drug-Eluting Stents Consumption by Type
- 7.4.2 China Drug-Eluting Stents Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Drug-Eluting Stents Consumption by Type
- 7.5.2 Rest of World Drug-Eluting Stents Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Boston Scientific
- 8.1.1 Boston Scientific Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Drug-Eluting Stents
- 8.1.4 Drug-Eluting Stents Product Introduction
- 8.1.5 Boston Scientific Recent Development
- 8.2 Medtronic, Inc.
- 8.2.1 Medtronic, Inc. Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Drug-Eluting Stents
- 8.2.4 Drug-Eluting Stents Product Introduction
- 8.2.5 Medtronic, Inc. Recent Development
- 8.3 Abbott
- 8.3.1 Abbott Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Drug-Eluting Stents
- 8.3.4 Drug-Eluting Stents Product Introduction
- 8.3.5 Abbott Recent Development
- 8.4 Lepu Medical
- 8.4.1 Lepu Medical Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Drug-Eluting Stents
- 8.4.4 Drug-Eluting Stents Product Introduction
- 8.4.5 Lepu Medical Recent Development
- 8.5 MicroPort Scientific Corporation
- 8.5.1 MicroPort Scientific Corporation Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Drug-Eluting Stents
- 8.5.4 Drug-Eluting Stents Product Introduction
- 8.5.5 MicroPort Scientific Corporation Recent Development
- 8.6 Cook Medical
- 8.6.1 Cook Medical Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Drug-Eluting Stents
- 8.6.4 Drug-Eluting Stents Product Introduction
- 8.6.5 Cook Medical Recent Development
- 8.7 Terumo
- 8.7.1 Terumo Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Drug-Eluting Stents
- 8.7.4 Drug-Eluting Stents Product Introduction
- 8.7.5 Terumo Recent Development
- 8.8 Biosensors International
- 8.8.1 Biosensors International Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Drug-Eluting Stents
- 8.8.4 Drug-Eluting Stents Product Introduction
- 8.8.5 Biosensors International Recent Development
- 8.9 Balton
- 8.9.1 Balton Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Drug-Eluting Stents
- 8.9.4 Drug-Eluting Stents Product Introduction
- 8.9.5 Balton Recent Development
- 8.10 AlviMedica Medical Technologies
- 8.10.1 AlviMedica Medical Technologies Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Drug-Eluting Stents
- 8.10.4 Drug-Eluting Stents Product Introduction
- 8.10.5 AlviMedica Medical Technologies Recent Development
- 8.11 Biotronik
- 8.12 Shandong JW Medical
- 8.13 Sino Medical
- 8.14 Beijing AMSINO
- 8.15 Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Drug-Eluting Stents Capacity, Production Forecast 2019-2025
- 9.1.2 Global Drug-Eluting Stents Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Drug-Eluting Stents Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Drug-Eluting Stents Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Drug-Eluting Stents Production Forecast by Type
- 9.7.2 Global Drug-Eluting Stents Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Drug-Eluting Stents Sales Channels
- 10.2.2 Drug-Eluting Stents Distributors
- 10.3 Drug-Eluting Stents Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Drug-Eluting Stents. Industry analysis & Market Report on Drug-Eluting Stents is a syndicated market report, published as Global (United States, European Union and China) Drug-Eluting Stents Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Drug-Eluting Stents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
